Buffalo R&D Tax Credit Explained for Businesses

R&D Tax Credits for Buffalo, New York Businesses

Buffalo, New York, thrives in industries such as healthcare, education, manufacturing, finance, and tourism. Top companies in the city include Kaleida Health, a leading healthcare provider; the University at Buffalo, a major educational institution; General Motors, a significant manufacturing employer; M&T Bank, a key player in the finance sector; and Niagara Falls, a prominent tourism attraction. The R&D Tax Credit can provide tax savings for these industries by incentivizing innovation and technological advancements. This allows businesses to reinvest in R&D oosting their competitiveness and contributing to Buffalo’s economic growth.

find out more

Are you eligible?

Why choose us?

Pass an Audit?

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 350 Northern Blvd, Albany, New York is less than 290 miles away from Buffalo and provides R&D tax credit consulting and advisory services to Buffalo and the surrounding areas such as: Amherst, Cheektowaga, Tonawanda, Hamburg and Lancaster.

If you have any questions or need further assistance, please call or email our local New York Partner on (518) 801-0616.
Feel free to book a quick teleconference with one of our New York R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.

Schedule a Teleconference

Buffalo, New York Patent of the Year – 2024/2025

Efferent Labs Inc. has been awarded the 2024/2025 Patent of the Year for its breakthrough in real-time, in vivo biosensing. Their invention, detailed in U.S. Patent No. 11877866, titled ‘Implantable apparatus for sensing biologic signals’, introduces a miniaturized device that uses living cells to monitor physiological changes inside the body.

This implantable system features a sample chamber containing live, treated cells that fluoresce when exposed to specific light wavelengths. An integrated optical sensor emits excitation light and detects the resulting fluorescence, which reflects the body’s biochemical environment. The device includes a signal processor that interprets these signals and can transmit data wirelessly, enabling continuous monitoring without the need for invasive procedures.

By maintaining fluid communication between the implanted cells and the host organism, the apparatus ensures accurate, real-time readings of biological signals. Its design addresses challenges like minimizing interference from ambient light and protecting sensitive components from bodily fluids, enhancing both reliability and patient safety.

Efferent Labs’ innovation offers a significant advancement in medical diagnostics, providing clinicians with a powerful tool for monitoring chronic conditions and assessing treatment efficacy. This technology has the potential to transform patient care by enabling timely interventions based on precise, real-time data.